Cheyne-Stokes respiration. A review of clinical manifestations and critique of physiological mechanisms.
D000328:Adult; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D000818:Animals; D001549:Benzamides / Q000627:therapeutic use; D001794:Blood Pressure; D001927:Brain Diseases / Q000503:physiopathology*; D002245:Carbon Dioxide / Q000097:blood; D002555:Cerebrospinal Fluid; D002639:Cheyne-Stokes Respiration / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006331:Heart Diseases / Q000503:physiopathology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D008526:Medulla Oblongata / Q000503:physiopathology*; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D012119:Respiration; D012125:Respiratory Center / Q000503:physiopathology; D012154:Reticular Formation / Q000503:physiopathology*; D013806:Theophylline / Q000627:therapeutic use; D014692:Ventilation-Perfusion Ratio
D001549:Benzamides; D002245:Carbon Dioxide; D000628:Aminophylline; D013806:Theophylline; D010100:Oxygen